FREE Case Review (866) 588-0600

Zofran Plaintiffs Fight GSK’s Request to Redact Birth Defect Docs

Plaintiffs in the Zofran MDL (multidistrict litigation) in Boston have filed a motion which argues that the manufacturer of Zofran should not have the right to unilaterally redact documents which it deems as “highly confidential.”

Plaintiffs involved in the Zofran multidistrict litigation (MDL 2657) currently underway in Boston have filed a motion arguing that GlaxoSmithKline (GSK) should not be granted the right to unilaterally redact documents it deems “highly confidential.”

Free Confidential Lawsuit Evaluation: If your child or other loved one was born with a birth defect after the mother took Zofran in pregnancy, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer and our lawyers can help.

What’s the Problem?

March 21, 2016 – Although the plaintiffs and GSK did reach an agreement over a Protective Order (PDF) which will keep the drugmaker’s internal corporate documents and any personal information of the plaintiff’s confidential, GSK is now seeking the ability to single-handedly decide what it chooses to redact. If this is allowed, the company will be able to censor information which could be relevant to the case, without anyone outside of the company knowing that it even exists.

Plaintiffs responded to the request by stating that “information GSK believes is a trade secret or otherwise highly confidential or irrelevant should be produced in unredacted form and designated as Confidential Information in accordance with the proposed Protective Order, which expressly allows such qualifying material to be designated confidential.”

MDL 2657 now includes over 230 federal lawsuits alleging that Zofran (generic: ondansetron) caused birth defects in babies exposed to the drug in the womb. Problems linked to Zofran include heart defects, cleft lip / cleft palate, kidney defects and clubfoot.

Zofran was approved by the U.S. Food & Drug Administration (FDA) 1991 for the treatment of nausea and vomiting associated with cancer treatment (chemotherapy, radiation) and certain types of surgery; the medication has never been approved to treat the symptoms of morning sickness. Despite this fact, GSK launched a marketing campaign which focused on prescribing Zofran to pregnant women with morning sickness. Zofran soon became the top-selling medication for pregnant women to ease their nausea.

Do I Have a Zofran Lawsuit?

The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Zofran lawsuits. We are handling individual litigation nationwide and currently accepting new birth defect cases in all 50 states.

Free Confidential Case Evaluation: Again, if your child was injured by Zofran side effects, you should contact our law firm immediately. You may be entitled to a settlement by filing a lawsuit and we can help.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
Awards & recognition